{
    "nctId": "NCT01796977",
    "briefTitle": "Using A Dissolved Oxygen Enriched Dressing in Nipple-sparing Mastectomy",
    "officialTitle": "A Prospective, Multi-Center, Randomized, Open Label Controlled Trial Using a Dissolved Oxygen Enriched Dressing in Nipple-sparing Mastectomy",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer, Reconstructive Breast Surgery",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 27,
    "primaryOutcomeMeasure": "Evaluate the Effects of OxyGenesys Dissolved Oxygen Dressing in Wound Complication Rates of the Nipple Areolar Complex Post Nipple-sparing Mastectomy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Subject is able to give written consent\n* Females \\>21 years of age\n* At least one breast diagnosed with cancer or mastectomy due to a positive BRCA gene mutation test.\n* Subject is indicated for bilateral nipple-sparing mastectomy surgery with immediate breast reconstruction\n* Subject is able to comply with the study protocol\n\nExclusion Criteria:\n\n* Primary tumor(s) located within 2cm of the areola margins\n* Inability to perform follow up assessments\n* Radiation treatment within 30 days of surgery\n* Dermabond or other forms of surgical glue is used in the peri-areola region\n* Subjects who are known to be allergic to any of the test product(s) or any component of the test product(s)\n* Women who are pregnant\n* Subjects who have been treated with an investigational drug or device within the past 30 days prior to enrollment",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}